Biotechnology BIOMARIN INVESTOR ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors of Lead Plaintiff Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. – BMRN October 7, 2020
Biotechnology BioNTech SE Sponsored ADR (BNTX) Gains But Lags Market: What You Should Know October 7, 2020
Biotechnology MERGER ALERT – GHIV, BBIO, and VRTU: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies October 7, 2020
Health Biotech Stock Roundup: ALXN to Raise Guidance, BMY to Buy MYOK & Other Updates October 7, 2020
Biotechnology Alkermes Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on ALKS 3831 October 7, 2020
Biotechnology CRISPR Therapeutics Congratulates Co-Founder Emmanuelle Charpentier on Receiving the 2020 Nobel Prize in Chemistry October 7, 2020
Biotechnology BioMarin, Pioneer in Rare Disease Treatments for Phenylketonuria (PKU), Receives FDA Approval of Label Expansion to Allow Maximum Dose of 60 mg for Palynziq® (pegvaliase-pqpz) Injection for Treatment of Adults with PKU October 7, 2020
Search
Biotechnology
